Outcome of ALL With ALL-BFM-95 Protocol in Nepal
PURPOSEData on survival outcomes in patients with acute lymphoblastic leukemia (ALL) originating from Nepal are limited. We aim to present the real-world data on treatment outcomes of patients with de novo ALL treated with pediatric ALL-Berlin-Frankfurt-Muenster (BFM)-95 protocol in Nepal.PATIENTS A...
Main Authors: | Bishesh Sharma Poudyal, Bishal Paudel, Sampurna Tuladhar, Samir Neupane, Kushal Bhattarai, Utsav Joshi |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society of Clinical Oncology
2023-06-01
|
Series: | JCO Global Oncology |
Online Access: | https://ascopubs.org/doi/10.1200/GO.22.00408 |
Similar Items
-
Hemophagocytic Lymphohistiocytosis: an Under-recognized and Life-threatening Condition
by: Bishesh Sharma Poudyal, et al.
Published: (2023-03-01) -
PB1747: OUTCOME OF CHILDHOOD ALLTREATED WITH ALL BFM IC 2009 PROTOCOL
by: Gizem Çilsaat, et al.
Published: (2023-08-01) -
Toxicity assessment of acute lymphoblastic leukemia treatment protocol ALL IC-BFM 2002
by: T. T. Valiev, et al.
Published: (2022-07-01) -
Cost-analysis of Treatment of Pediatrics Acute Lymphoblastic Leukemia based on ALL-BFM Protocol
by: Hadi Hayati, et al.
Published: (2016-09-01) -
Dermatological toxicity of acute lymphoblastic leukemia treatment by protocol ALL IC-BFM 2002
by: Timur T. Valiev, et al.
Published: (2022-08-01)